文献速递血栓与止血

由非功能阻断性抗αIIbβ3自身抗体导致的获得性血小板无力症独特表型

A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
PubMed 文献 · J Thromb Haemost · 2018-11-29

本文报道一例72岁男性获得性血小板无力症(aGT),其抗αIIbβ3自身抗体不阻断血小板功能,但导致血小板表面αIIbβ3表达显著降低至正常约5%,而血小板内αIIbβ3含量为正常的40-50%。抗体结合可能诱导αIIbβ3内化,从而产生aGT表型;诊断2年后出血症状改善,表面αIIbβ3恢复至正常20%,抗αIIbβ3抗体减少。

要点

  • 该aGT病例由非功能阻断性抗αIIbβ3抗体引起,表现为表面αIIbβ3显著降低而非功能抑制。
  • 患者血小板表面αIIbβ3降至正常约5%,但血小板内αIIbβ3为正常40-50%,且ITGA2B和ITGB3 cDNA无异常。
  • 抗体结合可能诱导αIIbβ3内化;诊断2年后表面αIIbβ3恢复至正常20%,出血症状改善。

核心结论

  • 本文展示了一例由血小板表面αIIbβ3显著降低导致的独特aGT表型,抗αIIbβ3抗体诱导的内化可能部分解释了该表型。

研究设计与样本

  • 病例报告:一名72岁男性,自50多岁起患免疫性血小板减少症,尽管血小板仅轻度减少,出血症状仍加重。
  • 方法包括血小板聚集试验、αIIbβ3表达分析、基因分析,以及患者抗αIIbβ3抗体对血小板功能和αIIbβ3表达影响的体外分析。

主要发现

  • 血小板聚集在所有激动剂下均缺失,但利托菌素(ristocetin)除外。
  • 血小板表面αIIbβ3表达显著降低至正常约5%,而血小板内αIIbβ3含量为正常40-50%,血小板内还检测到大量纤维蛋白原。
  • ITGA2B和ITGB3 cDNA无异常。
  • 血小板洗脱液和血浆中检测到抗αIIbβ3 IgG抗体,这些抗体不抑制PAC-1结合,表明为非功能阻断性。
  • 与患者抗体共孵育后,巨核细胞系和培养巨核细胞的表面αIIbβ3表达趋于受损;诊断aGT 2年后出血症状改善,表面αIIbβ3恢复至正常20%,抗αIIbβ3抗体减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials Acquired Glanzmann thrombasthenia (aGT) is generally caused by function-blocking antibodies (Abs). We demonstrated a unique aGT case due to marked reduction of αIIbβ3 with anti-αIIbβ3 Abs. The anti-αIIbβ3 Abs of the patient did not inhibit platelet function but reduced surface αIIbβ3. Internalization of αIIbβ3 induced by the Abs binding may be responsible for the phenotype. SUMMARY: Background Acquired Glanzmann thrombasthenia (aGT) is a bleeding disorder generally caused by function-blocking anti-αIIbβ3 autoantibodies. Aim We characterize an unusual case of aGT caused by marked reduction of surface αIIbβ3 with non-function-blocking anti-αIIbβ3 antibodies (Abs). Methods A 72-year-old male suffering from immune thrombocytopenia since his 50s showed exacerbation of bleeding symptom despite mild thrombocytopenia. Platelet aggregation was absent with all agonists but ristocetin. Analysis of αIIbβ3 expression and genetic analysis were performed. We also analyzed effects of anti-αIIbβ3 Abs of the patient on platelet function and αIIbβ3 expression. Results Surface αIIbβ3 expression was markedly reduced to around 5% of normal, whereas his platelets contained αIIbβ3 to the amount of 40-50% of normal. A substantial amount of fibrinogen was also detected in his platelets. There were no abnormalities in ITGA2B and ITGB3 cDNA. These results indicated that reduced surface αIIbβ3 expression caused a GT phenotype, and active internalization of αIIbβ3 was suggested. Anti-αIIbβ3 IgG Abs were detected in platelet eluate and plasma. These Abs did not inhibit PAC-1 binding, indicating that the Abs were non-function-blocking. Surface αIIbβ3 expression of a megakaryocytic cell line and cultured megakaryocytes tended to be impaired by incubation with the patient's Abs. After 2 years of aGT diagnosis, his bleeding symptom improved and surface αIIbβ3 expression was recovered to 20% of normal with reduction of anti-αIIbβ3 Abs. Conclusion We demonstrated a unique aGT phenotype due to marked reduction of surface αIIbβ3. Internalization induced by anti-αIIbβ3 Abs may be responsible in part for the phenotype.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Akuta K, Kashiwagi H, Yujiri T, et al. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies. J Thromb Haemost. 2018. PMID: 30388316. doi:10.1111/jth.14323

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。